U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 12-18, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 12-18, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 06/14/2022
Location: Virtual
Subject: Food and Drug Law Institute (FDLI) Annual Meeting: Exploring Advanced Topics in Food
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 06/14/2022
Location: Virtual
Subject: FDA Science Board
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government and other registered guests

Event Date: 06/15/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Robert Ford (Abbott Laboratories);

Event Date: 06/16/2022
Location: Virtual
Subject: National Black Family Cancer Awareness Week; Engaging the Generations
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, and other registered guests

Event Date: 06/16/2022
Location: Virtual
Subject: 2022 Biotechnology Innovation Organization International Convention; Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 06/17/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in the infant formula issues

Event Date: 06/17/2022
Location: Washington, DC
Subject: Over-the-Counter Medicines, Dietary Supplements, and Consumer Medical Devices
FDA Participant/Group: MICHELLE ADAMS;
Non FDA Participant/Group: Members of the Consumer Healthcare Products Association and staff

Event Date: 06/17/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Alexandre Biella, Audrae Erickson, Geoffroy Ribadeau-Dumas, Niall Mullane, Robert Cleveland (Reckitt);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 06/13/2022
Location: Washington, DC
Subject: Patient-Centered Outcomes Research Institute (PCORI) Board of Governors Executive Session Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Board of Governors

Event Date: 06/14/2022
Location: Washington, DC
Subject: Patients Rising Now; Meet and Greet
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Patients Rising Now

Event Date: 06/15/2022
Location: Washington, DC
Subject: Food and Drug Law Institute (FDLI) Annual Meeting; Speaker: Dr. Harvey Wiley Lecture and Award
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 06/15/2022
Location: Virtual
Subject: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) -2/-3/-6 Trial Oversight Committee Meeting
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Participants interested in accelerating COVID-19 Therapeutic Interventions and Vaccines

Event Date: 06/16/2022
Location: Virtual
Subject: Patient-Centered Outcomes Research Institute (PCORI) Cycle 3 2021 Selection Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the Selection Committee

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 06/15/2022
Location: Virtual
Subject: Food Safety Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Farm to Fork Initiative

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 06/13/2022
Location: Glendale, AZ
Subject: The Association of Food and Drug Officials (AFDO) Annual Education Conference; ORA Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of AFDO

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 06/14/2022
Location: Virtual
Subject: Food and Drug Law Institute (FDLI) Annual Meeting; Speaker: CDER Priorities and Goals
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 06/14/2022
Location: Virtual
Subject: Biotechnology Innovation Organization (BIO) International Convention; Panelist: FDA Town Hall
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Industry, research, and academic stakeholders

Event Date: 06/15/2022
Location: Virtual
Subject: d(eb)ra (EB Epidermolysis Bullosa) of America Listening Session
FDA Participant/Group: JULIE BEITZ; JACQUELINE CORRIGAN CURAY; SHAWN BROOKS; KENDALL MARCUS; SHARI TARGUM;
Non FDA Participant/Group: Representatives of d(eb)ra of America and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/14/2022
Location: Virtual
Subject: Vaccines and Related Biological Products Advisory Committee (VRBPAC) 174th Meeting; Speaker: Session Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and the public

Event Date: 06/14/2022
Location: Virtual
Subject: Biotechnology Innovation Organization (BIO) International Convention; Speaker: Realizing the Promise of Gene Therapy - Current Challenges, Opportunities, and Trends
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academic stakeholders

Event Date: 06/15/2022
Location: Virtual
Subject: Vaccines and Related Biological Products Advisory Committee (VRBPAC) 174th Meeting: Session Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and the public

Event Date: 06/16/2022
Location: Virtual
Subject: Food and Drug Law Institute (FDLI) Annual Meeting; Speaker: CDRH Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 06/17/2022
Location: Virtual
Subject: Ontario Student Assistance Program Annual Conference; Speaker: Vaccines Addressing COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, healthcare, and industry

Event Date: 06/18/2022
Location: Virtual
Subject: Philly Cell and Gene Therapy Annual Conference 2022; Speaker: FDA’s Efforts to Facilitate the Development of Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 06/14/2022
Location: Washington, DC
Subject: Food and Drug Law Institute (FDLI) Annual Meeting: CDRH Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 06/15/2022
Location: Virtual
Subject: Food and Drug Law Institute (FDLI) Annual Meeting; Speaker: CFSAN Priorities and Goals
FDA Participant/Group: DOUGLAS STEARN;
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 06/16/2022
Location: Virtual
Subject: Infant Formula Recall, Nutrition, and Labeling Issues
FDA Participant/Group: KARI BARRETT; REBECCA BUCKNER;
Non FDA Participant/Group: Amy Keating, Brian Ronholm, James Rogers (Consumer Reports);

Official Name: Michele Mital, Acting Director, Center for Tobacco Products

Event Date: 06/15/2022
Location: Virtual
Subject: Food and Drug Law Institute (FDLI) Annual Meeting; Speaker: CTP Priorities and Goals
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 06/14/2022
Location: Virtual
Subject: Food and Drug Law Institute (FDLI) Annual Meeting; Speaker: CVM Priorities and Goals
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top